Loading...

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis

Sodium butyrate (SoB) supplementation has been suggested to attenuate the development of non-alcoholic fatty liver disease (NAFLD). Here, we determined the therapeutic potential of SoB on NAFLD progression and molecular mechanism involved. Eight-week old C57BL/6J mice were pair-fed a fat-, fructose-...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Nutrients
Main Authors: Baumann, Anja, Jin, Cheng Jun, Brandt, Annette, Sellmann, Cathrin, Nier, Anika, Burkard, Markus, Venturelli, Sascha, Bergheim, Ina
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7231312/
https://ncbi.nlm.nih.gov/pubmed/32235497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu12040951
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!